IRCT20200407046981N32尚未招募未知
Comparative bioequivalence study of the Lithium carbonate 300-mg tablets manufactured by Ahran Tejarat Pharmaceutical Company versus standard tablets (Sun Pharma)
Ahran Tejarat Pharmaceutical Company0 个研究点目标入组 24 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 50 years（—）
- 性别
- Male
入选标准
- •The weight limit of each volunteer should be between 60 and 100 kg.
- •All volunteers must be non-smokers.
- •They must be healthy in terms of liver, kidney, respiratory system, mental and other general health characteristics that will be assessed.
- •Candidates who have consented to the consent form.
排除标准
- •Known hypersensitivity or idiosyncratic reaction to Lithium carbonate or any ingredients.
- •Subjects with BP = 90/60 mm/Hg or BP = 140/90 mm/Hg.
- •Regular smoker who smokes more than ten cigarettes daily.
- •Taking any medicine during two weeks before dosing.
研究者
相似试验
已完成
Unknown
ithium carbonate tablet bioequivalenceBioequivalence study in healthy volunteers.IRCT20130313012810N26Behestan Daru Co24
已完成
Unknown
ithium carbonate tablet bioequivalenceIRCT20130313012810N25Baharpaya Pharmaceutical Company24
尚未招募
不适用
Study of absorption and elimination rate of Linagliptin tablets 5 mg in comparison with Linagliptin brand tablets (Tradjenta®).Bioequivalence study.IRCT20200407046981N37Darmanyab darou pharmaceutical company24
已完成
Unknown
Comparative bioequivalence study of the extended release tamsulosin hydrochloride 0.4 mg tablet manufactured by Tasnim CompanyBioequivalence study in healthy volunteers.IRCT20130313012810N19Tasnim pharmaceutical Company24
已完成
不适用
Comparative bioequivalence study of the Nicorandil 20-mg tablets manufactured by Modava Pharmaceoutical companyIRCT20130313012810N6Modava Pharmaceutical Company24